These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2128141)

  • 21. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Differences in platelet aggregation in various microangiopathic complications of diabetes mellitus].
    Szénási P; Tóth L; Kammerer L; Romics L
    Orv Hetil; 1989 Mar; 130(12):617-20. PubMed ID: 2649841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects.
    Rao AK; Willis J; Holmsen H
    J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
    Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of hypercholesterolemia on function of platelets].
    Qi AD
    Sheng Li Ke Xue Jin Zhan; 1990 Oct; 21(4):310-3. PubMed ID: 2100884
    [No Abstract]   [Full Text] [Related]  

  • 26. Fractal analysis of circulating platelets in type 2 diabetic patients.
    Bianciardi G; Tanganelli I
    Clin Hemorheol Microcirc; 2015; 61(1):91-7. PubMed ID: 25335814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet Dysfunction in Type 1 Diabetes: Stressing the Thromboxanes.
    Wisinski JA; Kimple ME
    Diabetes; 2016 Feb; 65(2):349-51. PubMed ID: 26798121
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelets, vascular disease, and diabetes mellitus.
    Winocour PD
    Can J Physiol Pharmacol; 1994 Mar; 72(3):295-303. PubMed ID: 8069776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium homeostasis and eicosanoid formation in human platelets.
    Brüne B; von Appen F; Ullrich V
    Prostaglandins Leukot Essent Fatty Acids; 1993 Apr; 48(4):277-89. PubMed ID: 8497490
    [No Abstract]   [Full Text] [Related]  

  • 30. Metabolites of arachidonic acid in activating platelets and their estimation by radionuclide techniques.
    Sinzinger H
    Hell J Nucl Med; 2006; 9(2):111; author reply 111-2. PubMed ID: 16894418
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical significance of blood platelet activation in pathogenesis of respiratory tract disorders].
    Rybacka-Chabros B
    Pneumonol Alergol Pol; 1995; 63(3-4):234-6. PubMed ID: 7647742
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo platelet activation in diabetes mellitus.
    Strano A; Davì G; Patrono C
    Semin Thromb Hemost; 1991 Oct; 17(4):422-5. PubMed ID: 1803512
    [No Abstract]   [Full Text] [Related]  

  • 33. [Physiologically active substances derived from activated platelets: overview in clinical medicine].
    Yatomi Y
    Nihon Naika Gakkai Zasshi; 2008 Jan; 97(1):168-75. PubMed ID: 18363212
    [No Abstract]   [Full Text] [Related]  

  • 34. Platelet activation and its detection during the preparation of platelets for transfusion.
    Rinder HM; Ault KA
    Transfus Med Rev; 1998 Oct; 12(4):271-87. PubMed ID: 9798270
    [No Abstract]   [Full Text] [Related]  

  • 35. Platelet function and Isoprostane biology. Should isoprostanes be the newest member of the orphan-ligand family?
    Ting HJ; Khasawneh FT
    J Biomed Sci; 2010 Apr; 17(1):24. PubMed ID: 20370921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influencing factors in quantitative measurement using activated platelet levels and platelet-activating capacity for the assessment of thrombosis in pre-metabolic syndrome and type 2 diabetes mellitus.
    Okano K; Shitamoto K; Araki M; Kawamoto C; Kawano R; Nogaki H
    Nurs Health Sci; 2018 Mar; 20(1):69-78. PubMed ID: 29235231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in functional roles between activated platelets and platelet-derived microparticles.
    Nomura S; Inami N; Iwasaka T
    Thromb Haemost; 2007 Nov; 98(5):1143-4. PubMed ID: 18000624
    [No Abstract]   [Full Text] [Related]  

  • 38. Integrin signaling: the platelet paradigm.
    Shattil SJ; Kashiwagi H; Pampori N
    Blood; 1998 Apr; 91(8):2645-57. PubMed ID: 9531572
    [No Abstract]   [Full Text] [Related]  

  • 39. A tour through the transcriptional landscape of platelets.
    Schubert S; Weyrich AS; Rowley JW
    Blood; 2014 Jul; 124(4):493-502. PubMed ID: 24904119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White cell and thrombocyte disorders. Standardized, self-learning flow cytometric list mode data classification with the CLASSIF1 program system.
    Valet G; Valet M; Tschöpe D; Gabriel H; Rothe G; Kellermann W; Kahle H
    Ann N Y Acad Sci; 1993 Mar; 677():233-51. PubMed ID: 8494212
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.